CCM Blood Biomarker Validation Study
Learn more about:
Related Clinical Trial
Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)
CCM Blood Biomarker Validation Study
The Symptomatic Cerebral Cavernous Malformation Trial of REC-994
Biomarkers of CASH
CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness
Modifiers of Disease Severity in Cerebral Cavernous Malformations
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study
Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins